Faruqi & Faruqi investigates Skye Biosciences securities class action.

miércoles, 3 de diciembre de 2025, 9:58 am ET1 min de lectura
SKYE--

Faruqi & Faruqi LLP is investigating potential claims against Skye Biosciences, Inc. over alleged securities fraud. Investors who purchased Skye securities between November 4, 2024 and October 3, 2025 are encouraged to contact Josh Wilson at 877-247-4292 or 212-983-9330 (Ext. 1310) to discuss their legal options. The deadline to seek lead plaintiff status is January 16, 2026.

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios